August 19, 2019

A machine to bio-engineer skin-grafts

Swiss researchers want to develop the first-ever automated machine to bioengineer personalised skin grafts for therapy. The denovoCast project, a collaboration between life science start-up Cutiss AG and CSEM, has been awarded a grant of more than CHF 800’000 by Innosuisse.

CUTISS personalized bio-engineered skin graft ready for transplantation
Download press release
Download pictures

Related Press

Customized skin tissue grafts

24 June 2021

CUTISS

CUTISS AG, a Swiss clinical-stage life sciences company focused on skin regenerative medicine and tissue engineering, has unveiled the world’s first automated machine to produce customized skin tissue...

A hand holding a bioreactor to grow vein grafts developed by CSEM and ClexBio

22 February 2024

CSEM and ClexBio create a bioreactor for tissue-engineered cardiovascular implants

The teams at CSEM and at ClexBio have developed a process for engineering vein grafts comprised of human tissue material that integrates into the patient’s body and can turn into real, living tissue....

(Left to Right) A. Schueller, Founder and CEO; This Egloff, Scientist (cellvie); Charlotte Fonta, Senior R&D Engineer; and Gilles Weder, Head R&BD, Life Science Technologies, CSEM.

3 September 2025

Breakthrough in mitochondria therapy: CSEM and cellvie automate isolation process for clinical use

cellvie and CSEM are advancing an automated solution to standardize mitochondrial therapy manufacturing, accelerating treatment for ischemia-reperfusion injury and potentially helping over 3 million p...